Literature DB >> 18672088

Histoplasma capsulatum at the host-pathogen interface.

Joshua D Nosanchuk1, Attila Gacser.   

Abstract

Histoplasma capsulatum is the most common cause of invasive fungal pulmonary disease worldwide. The interaction of H. capsulatum with a host is a complex, dynamic process. Severe disease most commonly occurs in individuals with compromised immunity, and the increasing utilization of immunomodulators in medicine has revealed significant risks for reactivation disease in patients with latent histoplasmosis. Fortunately, there are well developed molecular tools and excellent animal models for studying H. capsulatum virulence and numerous recent advances have been made regarding the pathogenesis of this fungus that will improve our capacity to combat disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18672088      PMCID: PMC2586805          DOI: 10.1016/j.micinf.2008.07.011

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  59 in total

1.  Identification of a copper-inducible promoter for use in ectopic expression in the fungal pathogen Histoplasma capsulatum.

Authors:  Dana Gebhart; Adam K Bahrami; Anita Sil
Journal:  Eukaryot Cell       Date:  2006-06

2.  Determination of beta-glucosidase enzymatic function of the histoplasma capsulatum H antigen using a native expression system.

Authors:  K L Fisher; J P Woods
Journal:  Gene       Date:  2000-04-18       Impact factor: 3.688

3.  Agrobacterium tumefaciens integrates transfer DNA into single chromosomal sites of dimorphic fungi and yields homokaryotic progeny from multinucleate yeast.

Authors:  Thomas D Sullivan; Peggy J Rooney; Bruce S Klein
Journal:  Eukaryot Cell       Date:  2002-12

4.  Monitoring phase-specific gene expression in Histoplasma capsulatum with telomeric GFP fusion plasmids.

Authors:  S Kügler; B Young; V L Miller; W E Goldman
Journal:  Cell Microbiol       Date:  2000-12       Impact factor: 3.715

5.  Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.

Authors:  David van Duin; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 6.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

7.  Experimental histoplasmosis in mice treated with anti-murine interferon-gamma antibody and in interferon-gamma gene knockout mice.

Authors:  K V Clemons; W C Darbonne; J T Curnutte; R A Sobel; D A Stevens
Journal:  Microbes Infect       Date:  2000-07       Impact factor: 2.700

8.  Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-alpha activity.

Authors:  George S Deepe
Journal:  Clin Infect Dis       Date:  2005-08-01       Impact factor: 9.079

Review 9.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

10.  Histoplasma capsulatum synthesizes melanin-like pigments in vitro and during mammalian infection.

Authors:  Joshua D Nosanchuk; Beatriz L Gómez; Sirida Youngchim; Soraya Díez; Philip Aisen; Rosely M Zancopé-Oliveira; Angela Restrepo; Arturo Casadevall; Andrew J Hamilton
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more
  11 in total

Review 1.  Innate antifungal immunity: the key role of phagocytes.

Authors:  Gordon D Brown
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

2.  Changes in membrane fluid state and heat shock response cause attenuation of virulence.

Authors:  Amalia Porta; Annamaria Eletto; Zsolt Török; Silvia Franceschelli; Attila Glatz; László Vígh; Bruno Maresca
Journal:  J Bacteriol       Date:  2010-02-05       Impact factor: 3.490

Review 3.  Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review.

Authors:  R Martin-Iguacel; J Kurtzhals; G Jouvion; S D Nielsen; J M Llibre
Journal:  Infection       Date:  2014-03-14       Impact factor: 3.553

Review 4.  Histoplasma Capsulatum: Mechanisms for Pathogenesis.

Authors:  Jamie Mittal; Maria G Ponce; Inessa Gendlina; Joshua D Nosanchuk
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

5.  Systemic canine histoplasmosis: A case report from Ecuador.

Authors:  Julio R Ortiz-Yépez; David A Ortega-Paredes; Pedro M Barba; Paola M Mafla-Endara; Jeannete Zurita
Journal:  Med Mycol Case Rep       Date:  2015-07-03

6.  Cutaneous histoplasmosis disclosing an HIV-infection.

Authors:  Silvio Alencar Marques; Maria Regina Cavariani Silvares; Rosangela Maria Pires de Camargo; Mariangela Esther Alencar Marques
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

7.  Oropharyngeal histoplasmosis: The diagnosis lies in the biopsy.

Authors:  Claudia Miranda; Michael A Jaker; Valerie A Fitzhugh-Kull; Lisa L Dever
Journal:  IDCases       Date:  2017-12-14

8.  Concentration-dependent protein loading of extracellular vesicles released by Histoplasma capsulatum after antibody treatment and its modulatory action upon macrophages.

Authors:  Ludmila Matos Baltazar; Daniel Zamith-Miranda; Meagan C Burnet; Hyungwon Choi; Leonardo Nimrichter; Ernesto S Nakayasu; Joshua D Nosanchuk
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

9.  CD103+ Conventional Dendritic Cells Are Critical for TLR7/9-Dependent Host Defense against Histoplasma capsulatum, an Endemic Fungal Pathogen of Humans.

Authors:  Nancy Van Prooyen; C Allen Henderson; Davina Hocking Murray; Anita Sil
Journal:  PLoS Pathog       Date:  2016-07-26       Impact factor: 6.823

10.  An unusual cause of fever in a patient with common variable immunodeficiency.

Authors:  Andrew T Dang; Gene Schwartz; LaQuita Jones; Michael J Absalon; Richard L McMasters; Amal Assa'ad
Journal:  Ann Allergy Asthma Immunol       Date:  2017-09       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.